← All MEPs

Bas Eickhout

European Parliament · 🇳🇱 Netherlands · former MEP

Term: from 18 July 2019 to 18 June 2026

Participation in roll-call votes

94 % of the 2,399 roll-call votes held during their term: took part in the vote (for, against or abstention)

Participation month by month

0 % 50 % 100 % July 2019 : participation 100 % (1 / 1), presence 100 % (1 / 1) 2019 September 2019 : participation 100 % (5 / 5), presence 100 % (5 / 5) October 2019 : participation 100 % (19 / 19), presence 100 % (19 / 19) November 2019 : participation 94 % (17 / 18), presence 94 % (17 / 18) December 2019 : participation 100 % (6 / 6), presence 100 % (6 / 6) January 2020 : participation 100 % (12 / 12), presence 100 % (12 / 12) 2020 February 2020 : participation 100 % (8 / 8), presence 100 % (8 / 8) May 2020 : participation 100 % (54 / 54), presence 100 % (54 / 54) June 2020 : participation 100 % (12 / 12), presence 100 % (12 / 12) July 2020 : participation 100 % (19 / 19), presence 100 % (19 / 19) September 2020 : participation 100 % (24 / 24), presence 100 % (24 / 24) October 2020 : participation 100 % (37 / 37), presence 100 % (37 / 37) November 2020 : participation 94 % (30 / 32), presence 94 % (30 / 32) December 2020 : participation 100 % (30 / 30), presence 100 % (30 / 30) January 2021 : participation 100 % (23 / 23), presence 100 % (23 / 23) 2021 February 2021 : participation 100 % (21 / 21), presence 100 % (21 / 21) March 2021 : participation 100 % (31 / 31), presence 100 % (31 / 31) April 2021 : participation 100 % (81 / 81), presence 100 % (81 / 81) May 2021 : participation 100 % (26 / 26), presence 100 % (26 / 26) June 2021 : participation 100 % (29 / 29), presence 100 % (29 / 29) July 2021 : participation 100 % (27 / 27), presence 100 % (27 / 27) September 2021 : participation 100 % (19 / 19), presence 100 % (19 / 19) October 2021 : participation 100 % (42 / 42), presence 100 % (42 / 42) November 2021 : participation 70 % (19 / 27), presence 70 % (19 / 27) December 2021 : participation 100 % (29 / 29), presence 100 % (29 / 29) January 2022 : participation 100 % (7 / 7), presence 100 % (7 / 7) 2022 February 2022 : participation 100 % (29 / 29), presence 100 % (29 / 29) March 2022 : participation 100 % (37 / 37), presence 100 % (37 / 37) April 2022 : participation 100 % (22 / 22), presence 100 % (22 / 22) May 2022 : participation 91 % (80 / 88), presence 91 % (80 / 88) June 2022 : participation 85 % (39 / 46), presence 85 % (39 / 46) July 2022 : participation 100 % (31 / 31), presence 100 % (31 / 31) September 2022 : participation 100 % (25 / 25), presence 100 % (25 / 25) October 2022 : participation 100 % (32 / 32), presence 100 % (32 / 32) November 2022 : participation 100 % (38 / 38), presence 100 % (38 / 38) December 2022 : participation 100 % (18 / 18), presence 100 % (18 / 18) January 2023 : participation 100 % (16 / 16), presence 100 % (16 / 16) 2023 February 2023 : participation 100 % (29 / 29), presence 100 % (29 / 29) March 2023 : participation 100 % (29 / 29), presence 100 % (29 / 29) April 2023 : participation 100 % (24 / 24), presence 100 % (24 / 24) May 2023 : participation 100 % (93 / 93), presence 100 % (93 / 93) June 2023 : participation 93 % (37 / 40), presence 93 % (37 / 40) July 2023 : participation 98 % (39 / 40), presence 98 % (39 / 40) September 2023 : participation 100 % (27 / 27), presence 100 % (27 / 27) October 2023 : participation 100 % (40 / 40), presence 100 % (40 / 40) November 2023 : participation 75 % (40 / 53), presence 75 % (40 / 53) December 2023 : participation 0 % (0 / 40), presence 0 % (0 / 40) January 2024 : participation 100 % (49 / 49), presence 100 % (49 / 49) 2024 February 2024 : participation 97 % (61 / 63), presence 97 % (61 / 63) March 2024 : participation 100 % (50 / 50), presence 100 % (50 / 50) April 2024 : participation 98 % (209 / 213), presence 98 % (209 / 213) July 2024 : participation 100 % (1 / 1), presence 100 % (1 / 1) September 2024 : participation 100 % (8 / 8), presence 100 % (8 / 8) October 2024 : participation 100 % (13 / 13), presence 100 % (13 / 13) November 2024 : participation 78 % (21 / 27), presence 78 % (21 / 27) December 2024 : participation 100 % (18 / 18), presence 100 % (18 / 18) January 2025 : participation 100 % (6 / 6), presence 100 % (6 / 6) 2025 February 2025 : participation 100 % (10 / 10), presence 100 % (10 / 10) March 2025 : participation 100 % (14 / 14), presence 100 % (14 / 14) April 2025 : participation 91 % (20 / 22), presence 91 % (20 / 22) May 2025 : participation 100 % (54 / 54), presence 100 % (54 / 54) June 2025 : participation 100 % (22 / 22), presence 100 % (22 / 22) July 2025 : participation 100 % (32 / 32), presence 100 % (32 / 32) September 2025 : participation 97 % (28 / 29), presence 97 % (28 / 29) October 2025 : participation 89 % (40 / 45), presence 89 % (40 / 45) November 2025 : participation 100 % (51 / 51), presence 100 % (51 / 51) December 2025 : participation 100 % (31 / 31), presence 100 % (31 / 31) January 2026 : participation 95 % (21 / 22), presence 95 % (21 / 22) 2026 February 2026 : participation 100 % (28 / 28), presence 100 % (28 / 28) March 2026 : participation 98 % (43 / 44), presence 98 % (43 / 44) April 2026 : participation 94 % (48 / 51), presence 94 % (48 / 51) May 2026 : participation 60 % (15 / 25), presence 60 % (15 / 25) June 2026 : participation 0 % (0 / 35), presence 0 % (0 / 35)

Their votes

2,399 votes

DateTextResultTheir vote
2018 discharge: European Environment Agency (EEA) For
2018 discharge: Shift2Rail Joint Undertaking (S2R Joint Undertaking) For
2018 discharge: IMI 2 Joint Undertaking For
2018 discharge: ECSEL Joint Undertaking For
2018 discharge: European Insurance and Occupational Pensions Authority (EIOPA) For
2018 discharge: Bio-based Industries Joint Undertaking (BBI Joint Undertaking) For
2018 discharge: Clean Sky 2 Joint Undertaking For
2018 discharge: Fuel Cells and Hydrogen 2 Joint Undertaking (FCH 2 Joint Undertaking) For
2021 budget: estimates of revenue and expenditure, Section I – European Parliament For
The draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified soybean MON 87708 × MON 89788 × A5547-127 For
The EU priorities for the 64th session of the UN Commission on the Status of Women For
The proposed mandate for negotiations for a new partnership with the United Kingdom of Great Britain and Northern Ireland For
An EU strategy to put an end to female genital mutilation around the world For
Protecting the EU’s internal market and consumer rights against the negative implications of the illegal trade in companion animals For
Trans-European energy infrastructure: Union list of projects of common interest For
European Central Bank - annual report 2018 For
EU/Vietnam Investment Protection Agreement Against
EU/Vietnam Free Trade Agreement Against
The gender pay gap For
The gender pay gap Against
A common charger for mobile radio equipment For
The situation in Venezuela after the illegal election of the new National Assembly Presidency and Bureau Against
Ongoing hearings under Article 7(1) of the TEU regarding Poland and Hungary For
Activities of the European Ombudsman - annual report 2018 For
The European Green Deal For
The European Parliament’s position on the Conference on the Future of Europe For
Resolution on implementing and monitoring the provisions on citizens’ rights in the Withdrawal Agreement For
Implementation of the common security and defence policy - annual report 2018 Against
Human rights and democracy in the world and the European Union's policy on the matter - annual report 2018 For
Implementation of the Common Foreign and Security Policy - annual report For
The situation of human rights and democracy in Nicaragua For
The commemoration of the 30th anniversary of the Romanian revolution of December 1989 Abstention
The rule of law in Malta following the recent revelations surrounding the murder of Daphne Caruana Galizia For
Fair taxation in a digitalised and globalised economy: BEPS 2.0 For
Public discrimination and hate speech against LGBTI people, including LGBTI free zones For
The draft Commission implementing regulation amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mancozeb, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin For
Cuba, the case of Jose Daniel Ferrer Against
The climate and environment emergency For
The EU's accession to the Istanbul Convention and other measures to combat gender-based violence For
The EU's accession to the Istanbul Convention and other measures to combat gender-based violence Against

Rows per page: 20 40 100 200 All